loadpatents
name:-0.082005023956299
name:-0.046999931335449
name:-0.017683982849121
Wang; Daqing Patent Filings

Wang; Daqing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Daqing.The latest application filed is for "household energy storage constant temperature battery system".

Company Profile
23.59.80
  • Wang; Daqing - Wilmington MA
  • Wang; Daqing - North Reading MA
  • Wang; Daqing - Shenzhen CN
  • WANG; Daqing - Bedford MA
  • Wang; Daqing - Westford MA
  • WANG; Daqing - San Mateo CA
  • Wang; Daqing - Cambridge MA
  • Wang; Daqing - Cambrige MA
  • Wang; Daqing - US
  • Wang, Daqing - Beijing CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Wavelength beam combining laser systems utilizing lens roll for chief ray focusing
Grant 11,353,715 - Deutsch , et al. June 7, 2
2022-06-07
Compositions and methods for inhibiting TIGIT gene expression
Grant 11,312,963 - Jiang , et al. April 26, 2
2022-04-26
Power Replenishment System And Method For Energy Storage Device
App 20220115891 - Xiao; Gang ;   et al.
2022-04-14
Multi-Port Energy Storage Battery
App 20220115884 - Wang; Daqing ;   et al.
2022-04-14
Battery Charging And Discharging Circuit
App 20220115887 - Wang; Daqing ;   et al.
2022-04-14
Household Energy Storage Constant Temperature Battery System
App 20220115721 - Wang; Daqing ;   et al.
2022-04-14
Immune Modulation With Tlr9 Agonists For Cancer Treatment
App 20220088054 - AGRAWAL; Sudhir ;   et al.
2022-03-24
Immune modulation with TLR9 agonists for cancer treatment
Grant 11,224,611 - Agrawal , et al. January 18, 2
2022-01-18
Immune Modulation With Tlr9 Agonists For Cancer Treatment
App 20210052625 - AGRAWAL; Sudhir ;   et al.
2021-02-25
Immune Modulation With Tlr9 Agonists For Cancer Treatment
App 20210038630 - AGRAWAL; Sudhir ;   et al.
2021-02-11
Immune modulation with TLR9 agonists for cancer treatment
Grant 10,835,550 - Agrawal , et al. November 17, 2
2020-11-17
Wavelength Beam Combining Laser Systems Utilizing Lens Roll For Chief Ray Focusing
App 20200333613 - Deutsch; Michael ;   et al.
2020-10-22
Immune modulation with TLR9 agonists for cancer treatment
Grant 10,772,907 - Agrawal , et al. Sept
2020-09-15
Smile Correction Using Fac Lens Deformation
App 20200285049 - Deutsch; Michael ;   et al.
2020-09-10
Compositions And Methods For Inhibiting Tigit Gene Expression
App 20200149050 - Jiang; Weiwen ;   et al.
2020-05-14
Immune Modulation With Tlr9 Agonists For Cancer Treatment
App 20200138848 - AGRAWAL; Sudhir ;   et al.
2020-05-07
Wavelength beam combining laser systems utilizing lens roll for chief ray focusing
Grant 10,627,639 - Deutsch , et al.
2020-04-21
Smile correction using FAC lens deformation
Grant 10,627,618 - Deutsch , et al.
2020-04-21
Treatment Of Cancer Using Tlr9 Agonist With Checkpoint Inhibitors
App 20200101102 - WANG; Daqing ;   et al.
2020-04-02
Machine Learning System For Genotyping Pcr Assays
App 20200075129 - WANG; Daqing ;   et al.
2020-03-05
Immune Modulation With Tlr9 Agonists For Cancer Treatment
App 20200054663 - AGRAWAL; Sudhir ;   et al.
2020-02-20
Immune modulation with TLR9 agonists for cancer treatment
Grant 10,463,686 - Agrawal , et al. No
2019-11-05
Wavelength Beam Combining Laser Systems Utilizing Lens Roll For Chief Ray Focusing
App 20190250417 - Deutsch; Michael ;   et al.
2019-08-15
Wavelength beam combining laser systems utilizing lens roll for chief ray focusing
Grant 10,241,338 - Deutsch , et al.
2019-03-26
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 10,066,230 - Kandimalla , et al. September 4, 2
2018-09-04
Optical alignment systems and methods for wavelength beam combining laser systems
Grant 10,067,351 - Zambuto , et al. September 4, 2
2018-09-04
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 10,041,076 - Kandimalla , et al. August 7, 2
2018-08-07
Compositions For Inhibiting Checkpoint Gene Expression And Uses Thereof
App 20180044669 - AGRAWAL; Sudhir ;   et al.
2018-02-15
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20180023085 - Kandimalla; Ekambar R. ;   et al.
2018-01-25
Compositions for inhibiting checkpoint gene expression and uses thereof
Grant 9,828,601 - Agrawal , et al. November 28, 2
2017-11-28
Wavelength Beam Combining Laser Systems Utilizing Lens Roll For Chief Ray Focusing
App 20170329147 - Deutsch; Michael ;   et al.
2017-11-16
Treatment Of Cancer Using Tlr9 Agonist With Checkpoint Inhibitors
App 20170274004 - Wang; Daqing ;   et al.
2017-09-28
Toll-like Receptor 9 Antagonist And Methods Of Use Thereof
App 20170268006 - Agrawal; Sudhir ;   et al.
2017-09-21
Wavelength beam combining laser systems utilizing lens roll for chief ray focusing
Grant 9,746,679 - Deutsch , et al. August 29, 2
2017-08-29
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20170233741 - Kandimalla; Ekambar R. ;   et al.
2017-08-17
Optical Alignment Systems And Methods For Wavelength Beam Combining Laser Systems
App 20170219835 - Zambuto; James ;   et al.
2017-08-03
Toll-like receptor 9 antagonist and methods of use thereof
Grant 9,688,993 - Agrawal , et al. June 27, 2
2017-06-27
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20170145417 - Kandimalla; Ekambar R. ;   et al.
2017-05-25
Optical alignment systems and methods for wavelength beam combining laser systems
Grant 9,658,461 - Zambuto , et al. May 23, 2
2017-05-23
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,540,651 - Kandimalla , et al. January 10, 2
2017-01-10
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160312225 - Kandimalla; Ekambar R. ;   et al.
2016-10-27
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,453,228 - Kandimalla , et al. September 27, 2
2016-09-27
Compositions For Inhibiting Checkpoint Gene Expression And Uses Thereof
App 20160251652 - Agrawal; Sudhir ;   et al.
2016-09-01
Toll-like Receptor 9 Antagonist And Methods Of Use Thereof
App 20160237437 - Agrawal; Sudhir ;   et al.
2016-08-18
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160215287 - Kandimalla; Ekambar R. ;   et al.
2016-07-28
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160201060 - Kandimalla; Ekambar ;   et al.
2016-07-14
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160138022 - Kandimalla; Ekambar R. ;   et al.
2016-05-19
Treatment Of Cancer Using Tlr9 Agonist With Checkpoint Inhibitors
App 20160101128 - Wang; Daqing ;   et al.
2016-04-14
Wavelength Beam Combining Laser Systems Utilizing Lens Roll For Chief Ray Focusing
App 20160048028 - Deutsch; Michael ;   et al.
2016-02-18
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,260,719 - Kandimalla , et al. February 16, 2
2016-02-16
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
Grant 9,243,050 - Kandimalla , et al. January 26, 2
2016-01-26
Lens Mounting Arrangements For High-power Laser Systems
App 20150364901 - Deutsch; Michael ;   et al.
2015-12-17
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,206,430 - Kandimalla , et al. December 8, 2
2015-12-08
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,096,858 - Kandimalla , et al. August 4, 2
2015-08-04
Smile Correction using FAC Lens Deformation
App 20150062891 - Deutsch; Michael ;   et al.
2015-03-05
Stabilized Immune Modulatory Rna (simra) Compounds For Tlr7 And Tlr8
App 20140308300 - Kandimalla; Ekambar R. ;   et al.
2014-10-16
Toll like receptor modulators
Grant 8,853,375 - Kandimalla , et al. October 7, 2
2014-10-07
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20140193396 - Kandimalla; Ekambar R. ;   et al.
2014-07-10
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
Grant 8,759,310 - Kandimalla , et al. June 24, 2
2014-06-24
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20140004100 - Kandimalla; Ekambar R. ;   et al.
2014-01-02
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20130267583 - Kandimalla; Ekambar R. ;   et al.
2013-10-10
Stabilized Immune Modulatory Rna (simra) Compounds For Tlr7 And Tlr8
App 20130202584 - Kandimalla; Ekambar R. ;   et al.
2013-08-08
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,486,908 - Kandimalla , et al. July 16, 2
2013-07-16
Compositions for inhibiting gene expression and uses thereof
Grant 8,431,544 - Agrawal , et al. April 30, 2
2013-04-30
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,426,375 - Kandimalla , et al. April 23, 2
2013-04-23
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,399,423 - Kandimalla , et al. March 19, 2
2013-03-19
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,383,598 - Kandimalla , et al. February 26, 2
2013-02-26
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,377,898 - Kandimalla , et al. February 19, 2
2013-02-19
Stabilized immune modulatory RNA (SIMRA) compounds
Grant 8,362,233 - Kandimalla , et al. January 29, 2
2013-01-29
Synthetic agonists of TLR9
Grant 8,361,986 - Kandimalla , et al. January 29, 2
2013-01-29
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,357,665 - Kandimalla , et al. January 22, 2
2013-01-22
Stabilized Immune Modulatory Rna (simra) Compounds
App 20120183530 - Kandimalla; Ekambar ;   et al.
2012-07-19
Synthetic RNA-based agonists of TLR7
Grant 8,202,974 - Lan , et al. June 19, 2
2012-06-19
Stabilized immune modulatory RNA (SIMRA) compounds
Grant 8,188,261 - Kandimalla , et al. May 29, 2
2012-05-29
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20120128699 - Kandimalla; Ekambar R. ;   et al.
2012-05-24
Synergistic Treatment Of Cancer Using Immunomers In Conjunction With Chemotherapeutic Agents
App 20120107303 - Kandimalla; Ekambar R. ;   et al.
2012-05-03
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
Grant 8,153,605 - Kandimalla , et al. April 10, 2
2012-04-10
Modulation of toll-like receptor 5 expression by antisense oligonucleotides
Grant 8,153,777 - Kandimalla , et al. April 10, 2
2012-04-10
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
Grant 8,106,173 - Kandimalla , et al. January 31, 2
2012-01-31
Compositions For Inhibiting Gene Expression And Uses Thereof
App 20120016004 - AGRAWAL; SUDHIR ;   et al.
2012-01-19
Novel Synthetic Agonists Of Tlr9
App 20110311518 - KANDIMALLA; EKAMBAR R. ;   et al.
2011-12-22
Novel Synthetic Agonists Of Tlr9
App 20110293565 - Kandimalla; Ekambar ;   et al.
2011-12-01
Synthetic agonists of TLR9
Grant 7,960,362 - Kandimalla , et al. June 14, 2
2011-06-14
Synthetic Agonists Of Tlr9
App 20110135669 - KANDIMALLA; EKAMBAR ;   et al.
2011-06-09
Potent Mucosal Immune Response Induced By Modified Immunomodulatory Oligonucleotides
App 20110123540 - Wang; Daqing ;   et al.
2011-05-26
Compositions For Inhibiting Gene Expression And Uses Thereof
App 20110082186 - Agrawal; Sudhir ;   et al.
2011-04-07
Synthetic agonists of TLR9
Grant 7,884,197 - Kandimalla , et al. February 8, 2
2011-02-08
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
Grant 7,875,594 - Kandimalla , et al. January 25, 2
2011-01-25
Oligonucleotide-based Compounds As Inhibitors Of Toll-like Receptors
App 20110009477 - Yu; Dong ;   et al.
2011-01-13
Synthetic Rna-based Agonists Of Tlr7
App 20100215642 - Lan; Tao ;   et al.
2010-08-26
Modulation of Toll-Like Receptor 4 Expression by Antisense Oligonucleotides
App 20100111936 - Putta; Mallikarjuna ;   et al.
2010-05-06
Modulation of Toll-Like Receptor 5 Expression by Antisense Oligonucleotides
App 20100111937 - Kandimalla; Ekambar ;   et al.
2010-05-06
Modulation of Toll-Like Receptor 2 Expression By Antisense Oligonucleotides
App 20100111935 - Bhagat; Lakshmi ;   et al.
2010-05-06
Modulation Of Myeloid Differentation Primary Response Gene 88 (myd88) Expression By Antisense Oligonucleotides
App 20100092486 - Kandimalla; Ekambar ;   et al.
2010-04-15
Modulation Of Toll-like Receptor 8 Expression By Antisense Oligonucleotides
App 20100047188 - Kandimalla; Ekambar ;   et al.
2010-02-25
Modulation Of Toll-like Receptor 3 Expression By Antisense Oligonucleotides
App 20100041735 - Kandimalla; Ekambar ;   et al.
2010-02-18
Modulation Of Toll-like Receptor 7 Expression By Antisense Oligonucleotides
App 20100041734 - Kandimalla; Ekambar ;   et al.
2010-02-18
Modulation Of Toll-like Receptor 9 Expression By Antisense Oligonucleotides
App 20100035967 - Kandimalla; Ekambar ;   et al.
2010-02-11
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
Grant 7,569,554 - Kandimalla , et al. August 4, 2
2009-08-04
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090098063 - Kandimalla; Ekambar R. ;   et al.
2009-04-16
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090087388 - Kandimalla; Ekambar ;   et al.
2009-04-02
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090081198 - Kandimalla; Ekambar ;   et al.
2009-03-26
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
App 20090060898 - Kandimalla; Ekambar R. ;   et al.
2009-03-05
Novel Synthetic Agonists Of Tlr9
App 20090053206 - Kandimalla; Ekambar R. ;   et al.
2009-02-26
Stabilized Immune Modulatory Rna (simra) Compounds
App 20090053205 - Kandimalla; Ekambar ;   et al.
2009-02-26
Toll Like Receptor Modulators
App 20090053148 - Kandimalla; Ekambar ;   et al.
2009-02-26
Synthetic Agonists Of Tlr9
App 20080292648 - Kandimalla; Ekambar ;   et al.
2008-11-27
Synergistic Treatment Of Cancer Using Immunomers In Conjunction With Chemotherapeutic Agents
App 20080206265 - Kandimalla; Ekambar R. ;   et al.
2008-08-28
Stabilized Immune Modulatory Rna (simra) Compounds For Tlr7 And Tlr8
App 20080171712 - Kandimalla; Ekambar R. ;   et al.
2008-07-17
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20080089883 - Kandimalla; Ekambar R. ;   et al.
2008-04-17
Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
App 20050222072 - Wang, Daqing ;   et al.
2005-10-06
Transmit power control method and radio arrangement
App 20050143012 - Gu, Jian ;   et al.
2005-06-30
Method and device for downlink packet access signaling for time division duplex (tdd) mode of a wireless communication system
App 20050117553 - Wang, Daqing ;   et al.
2005-06-02
Electroporation methods for introducing bioactive agents into cells
App 20040053873 - Barman, Shikha P. ;   et al.
2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed